TP53 and Miyoshi myopathy: In MM-resistant cell lines, primary cells from MM patients, and a TP53 mutant mouse model, the combination of PM, Pom, and DXM showed strong synergistic effects, suggesting a good combination therapy strategy for r/r MM in the clinic.